Correlation Between Sinphar Pharmaceutical and KS Terminals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sinphar Pharmaceutical and KS Terminals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sinphar Pharmaceutical and KS Terminals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sinphar Pharmaceutical Co and KS Terminals, you can compare the effects of market volatilities on Sinphar Pharmaceutical and KS Terminals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sinphar Pharmaceutical with a short position of KS Terminals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sinphar Pharmaceutical and KS Terminals.

Diversification Opportunities for Sinphar Pharmaceutical and KS Terminals

0.81
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Sinphar and 3003 is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Sinphar Pharmaceutical Co and KS Terminals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on KS Terminals and Sinphar Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sinphar Pharmaceutical Co are associated (or correlated) with KS Terminals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of KS Terminals has no effect on the direction of Sinphar Pharmaceutical i.e., Sinphar Pharmaceutical and KS Terminals go up and down completely randomly.

Pair Corralation between Sinphar Pharmaceutical and KS Terminals

Assuming the 90 days trading horizon Sinphar Pharmaceutical Co is expected to generate 0.31 times more return on investment than KS Terminals. However, Sinphar Pharmaceutical Co is 3.23 times less risky than KS Terminals. It trades about -0.22 of its potential returns per unit of risk. KS Terminals is currently generating about -0.12 per unit of risk. If you would invest  3,270  in Sinphar Pharmaceutical Co on September 25, 2024 and sell it today you would lose (340.00) from holding Sinphar Pharmaceutical Co or give up 10.4% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy98.44%
ValuesDaily Returns

Sinphar Pharmaceutical Co  vs.  KS Terminals

 Performance 
       Timeline  
Sinphar Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sinphar Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.
KS Terminals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days KS Terminals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Sinphar Pharmaceutical and KS Terminals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sinphar Pharmaceutical and KS Terminals

The main advantage of trading using opposite Sinphar Pharmaceutical and KS Terminals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sinphar Pharmaceutical position performs unexpectedly, KS Terminals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in KS Terminals will offset losses from the drop in KS Terminals' long position.
The idea behind Sinphar Pharmaceutical Co and KS Terminals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Other Complementary Tools

Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk